We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No huckster discount

20 July 2005 By Robert Cyran

Sure, profits are booming and there’s plenty of deal activity. But what’s really driving share prices up is decreasing risk aversion. Three years ago, nearly 15% of the top 250 US biotechs were worth less than their cash reserves. Today none are.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)